בחר את המומחה שלך

2,122
מומחים

 מומחים בשידור חי.
שאלו שאלות וקבלו תשובות אונליין.

5,704
תוכניות

וראיונות וידאו
עם מומחים מובילים מרחבי העולם

היועץ האישי שלי

חסכו זמן וכסף. התייעצו עם מומחה בוידאו. ועכשיו גם באפליקצייה



Ariel Averbuch - VOD אסקימופדיה

  • How to do patent searches?

    What is a patent registration and how does one begin this process?, How does an IP strategist ensure that no such patent exists prior?, What are the risks in attempting to deal with patenting on one's own, without legal counsel?, What are the risks to not immediately filing a patent application?, Anecdotes about patenting in the pharmaceutical/bio-tech industry These questions will be answered by Ariel Averbuch - Head of the Pharma & BioTech Dept., Patent Attorney & Advocate at Dr.D.Graeser Ltd.

  • What can be patented?

    What is the difference between intellectual property patents and patents for inventions? Does the process differ because one is tangible and the other is not?, What qualities much your IP have to qualify for a patent?, What types of costs and protection go into an IP patent?, How do you respond to the claim that there is ultimately no safe way of patenting an idea? i.e. US laws do not require you to have a prototype in order to apply for a patent, all that is required is that you be able to describe the invention so that others could both make and use it, What are the major myths surrounding IP law?, In terms of pharmaceuticals and bio-tech industry in which you specialize, is patenting a harder process considering most have to go through intense review (i.e. FDA) before it sees the public?, These questions will be answered by Ariel Averbuch - Head of the Pharma & BioTech Dept., Patent Attorney & Advocate at Dr.D.Graeser Ltd.

  • Intellectual property

    What is an intellectual property strategist?, What is the difference between intellectual property and copyright law - especially in the digital age?, Now in the digital age - what do entrepreneurs need to understand about intellectual property strategy?, How does this relate to your specialty in Pharmaceuticals and bio-tech industry?, If you were an IP manager in one of the companies competing in the pharma market, how would you decide how many patents you need to generate? How many do you need to license from? License to?, What is the core IP business model? These questions will be answered by Ariel Averbuch - Head of the Pharma & BioTech Dept., Patent Attorney & Advocate at Dr.D.Graeser Ltd.